Results 171 to 180 of about 260,714 (218)

Semi-mechanistic efficacy model for PARP + ATR inhibitors-application to rucaparib and talazoparib in combination with gartisertib in breast cancer PDXs. [PDF]

open access: yesBr J Cancer
Villette CC   +9 more
europepmc   +1 more source

Gender gap in medicine: a call to action for Latin America. [PDF]

open access: yesHum Resour Health
Negrotto L   +12 more
europepmc   +1 more source

A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250). [PDF]

open access: yesESMO Open
Navarro A   +18 more
europepmc   +1 more source

Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy. [PDF]

open access: yesFuture Oncol
Ivanyi P   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy